These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33768603)

  • 21. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
    Scharf M; Rogowski R; Hull S; Cohn M; Mayleben D; Feldman N; Ereshefsky L; Lankford A; Roth T
    J Clin Psychiatry; 2008 Oct; 69(10):1557-64. PubMed ID: 19192438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure.
    Valk PJ; Simons RM; Struyvenberg PA; Kruit H; van Berge Henegouwen MT
    Am J Rhinol; 1997; 11(1):27-33. PubMed ID: 9065344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acrivastine/pseudoephedrine (Semprex-D) for seasonal allergic rhinitis.
    Med Lett Drugs Ther; 1994 Sep; 36(930):78-80. PubMed ID: 7914667
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
    Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
    Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
    Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
    J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease: A Randomized Clinical Trial.
    Büchele F; Hackius M; Schreglmann SR; Omlor W; Werth E; Maric A; Imbach LL; Hägele-Link S; Waldvogel D; Baumann CR
    JAMA Neurol; 2018 Jan; 75(1):114-118. PubMed ID: 29114733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Traffic noise-induced sleep disturbances and their correction by an anxiolytic sedative, OX-373.
    Saletu B; Grünberger J
    Neuropsychobiology; 1981; 7(6):302-14. PubMed ID: 6118840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge.
    Empey DW; Frosolono MF; Hughes DT; Perkins JG
    Br J Clin Pharmacol; 1984 Jul; 18(1):86-9. PubMed ID: 6204666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep and pain in humans with fibromyalgia and comorbid insomnia: double-blind, crossover study of suvorexant 20 mg versus placebo.
    Roehrs T; Withrow D; Koshorek G; Verkler J; Bazan L; Roth T
    J Clin Sleep Med; 2020 Mar; 16(3):415-421. PubMed ID: 31992394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
    Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
    Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of acrivastine versus clemastine and placebo in the treatment of patients with chronic idiopathic urticaria.
    Leyh F; Harvey SG; Gibson JR; Manna VK
    J Int Med Res; 1989; 17 Suppl 2():22B-24B. PubMed ID: 2569997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acrivastine versus terfenadine in the treatment of symptomatic dermographism--a double-blind, placebo-controlled study.
    Boyle J; Marks P; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():9B-13B. PubMed ID: 2570004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria.
    van Joost T; Blog FB; Westerhof W; Jansen FC; Starink TM; den Boer MS; Kuneman JJ; Harvey SG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():14B-17B. PubMed ID: 2569995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomnia.
    Ratti E; Carpenter DJ; Zamuner S; Fernandes S; Squassante L; Danker-Hopfe H; Archer G; Robertson J; Alexander R; Trist DG; Merlo-Pich E
    Sleep; 2013 Dec; 36(12):1823-30. PubMed ID: 24293756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged treatment with acrivastine for seasonal allergic rhinitis.
    Bruno G; D'Amato G; Del Giacco GS; Locci F; Gale NM; Errigo E; Melillo G
    J Int Med Res; 1989; 17 Suppl 2():40B-46B. PubMed ID: 2570001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rhinitis therapy. Experiences with triprolidine hydrochloride/pseudoephedrin hydrochloride, a decongestive and antiallergic therapeutic agent].
    Bucke B; Distler HJ; Schoyerer R; Willner W
    Fortschr Med; 1983 Mar; 101(11):494-6. PubMed ID: 6133825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
    Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
    Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. French multicentre double-blind study to evaluate the efficacy and safety of acrivastine as compared with terfenadine in seasonal allergic rhinitis.
    Gervais P; Bruttman G; Pedrali P; Charpin J; Michel FB; Grilliat JP
    J Int Med Res; 1989; 17 Suppl 2():47B-53B. PubMed ID: 2570002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.